Amount of gain (loss) on sale or disposal of an equity method investment.

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 230
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 28
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482740/230-10-45-28

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(9)(a))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(7)(c))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Name:	us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Long-Term Investment (Details) - USD ($)	12 Months Ended
Long-Term Investment (Details) - USD ($)	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2021	Mar. 31, 2026
Long-Term Investment [Line Items]
Impairment loss	$ 1,607,537
Impairment carrying amount
Zhuoli Service [Member]
Long-Term Investment [Line Items]
Investment percentage				39.00%
Suffered loss		$ 2,402,376
Jiuzhou Pharmacy [Member]
Long-Term Investment [Line Items]
Injected funds			$ 1,443,752